Last Updated : October 14, 2022
Details
FilesGeneric Name:
selinexor
Project Status:
Complete
Therapeutic Area:
Multiple myeloma
Manufacturer:
FORUS Therapeutics Inc.
Call for patient/clinician input open:
Brand Name:
Xpovio
Project Line:
Reimbursement Review
Project Number:
PC0276-000
Call for patient/clinician input closed:
Tumour Type:
Myeloma
NOC Status at Filing:
Pre NOC
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
As per indication to be reviewed by CADTH: In combination with bortezomib (V) and dexamethasone (d) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
In combination with bortezomib (V) and dexamethasone (d) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
Key Milestones | |
|---|---|
| Call for patient/clinician input open | 09-Dec-21 |
| Call for patient/clinician input closed | 04-Feb-22 |
| Clarification: - Patient input submission received from Myeloma Canada | |
| Submission received | 14-Jan-22 |
| Submission accepted | 28-Jan-22 |
| Review initiated | 01-Feb-22 |
| Draft CADTH review report(s) provided to sponsor for comment | 18-Apr-22 |
| Deadline for sponsors comments | 27-Apr-22 |
| CADTH responses on draft review report(s) provided to sponsor | 27-May-22 |
| Expert committee meeting (initial) | 08-Jun-22 |
| Draft recommendation issued to sponsor | 22-Jun-22 |
| Draft recommendation posted for stakeholder feedback | 30-Jun-22 |
| End of feedback period | 15-Jul-22 |
| Final recommendation issued to sponsor and drug plans | 29-Jul-22 |
| Final recommendation posted | 17-Aug-22 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 15-Aug-22 |
| CADTH review report(s) posted | 13-Oct-22 |
Files
Last Updated : October 14, 2022